Funders › IN › Caroline Symmes Inc › 2024
Grants paid by Caroline Symmes Inc, tax year 2024
EIN 46-5643329 · Carmel, IN · Form 990, Schedule I · NTEE H12
In tax year 2024, Caroline Symmes Inc (EIN 46-5643329) reported 4 grants paid totaling $250,000. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2024
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | The Childrens' Oncology Group Foundation Philadelphia, PA | A | $100,000 | paid | Contribution to Project Every Child (PEC). PEC is a robust bank of blood and tissue samples from kids with cancer and it is opening the door to groundbreaking advances. | 202523009349301802 |
| 2024 | National Pediatric Cancer Foundation Tampa, FL | A | $100,000 | paid | Funding to support the NPCF's Sunshine Project research initiatives. Over 40 leading children's hospitals across the United States have joined the Sunshine Project Consortium because they believe in a singular mission: to find more effective and less toxic treatments for childhood cancer. The Sunshine Project has a 15-year track record of conducting novel treatment trials for children whose cancers were not curable by standard treatments. NPCF now find themselves at a critical juncture: it is clear that childhood cancer is too complex to expect one new treatment to cure all patients, or even to cure all patients with certain cancer types. To overcome this hurdle, the Sunshine Project has launched a multipronged assault on childhood cancer from many angles. | 202523009349301802 |
| 2024 | Indiana University Foundation Dr Vik's Ampath Lab Indianapolis, IN | A | $25,000 | paid | Donation by the Teen Board used in Dr Vik's Ampath lab. Ampath Kenya is a partnership between Moi University, Moi Teaching and Referral Hospital, the AMPATH Consortium of universities around the world led by Indiana University, and the Kenyan Government. Together, they work to build holistic, sustainable health in Kenya and around the world. | 202523009349301802 |
| 2024 | Oncoheros Biosciences Inc Holliston, MA | A | $25,000 | paid | To fund research developing Volasertib, a drug for children and adolescents with cancer. | 202523009349301802 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.